Up-regulation of Receptor Activator Nuclear Factor-Kappa B Ligand Expression by Root Canal Sealers in Human Osteoblastic Cells

Journal of Endodontics

Volumn 35, Issue 3, 2009, Pages 363-366

  Huang, Fu Mei ^a,b   Lee, Shiuan Shinn ^b   Yang, Shun Fa ^b   Chang, Yu Chao ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Osteoblastic cells; RANKL; root canal sealers

Indexed keywords

AH 26 FILLING MATERIAL; BISMUTH; CANALS SEALER; EPOXY RESIN; EUGENOL; FLUORESCENT DYE; FORMALDEHYDE; MESSENGER RNA; N2 DENTAL CEMENT; OSTEOCLAST DIFFERENTIATION FACTOR; ROOT CANAL FILLING MATERIAL; SILVER; TITANIUM; ZINC OXIDE; ZINC OXIDE EUGENOL;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL SURVIVAL; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; OSTEOBLAST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION;

APOPTOSIS; BISMUTH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPOXY RESINS; EUGENOL; FLUORESCENT DYES; FORMALDEHYDE; GENE EXPRESSION; HUMANS; OSTEOBLASTS; RANK LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROOT CANAL FILLING MATERIALS; SILVER; TITANIUM; UP-REGULATION; ZINC OXIDE; ZINC OXIDE-EUGENOL CEMENT;

EID: 60649102477     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joen.2008.11.020     Document Type: Article

References (37)

1. Holland R., and de Souza V. Ability of a new calcium hydroxide root canal filling material to induced hard tissue formation. J Endod 11 (1985) 535-543
2. Lambjerg-Hansen H. Vital pulpectomy and root filling with N2 or Endomethasone. Int Endod J 20 (1987) 194-204
3. Tagger M., and Tagger E. Periapical reactions to calcium hydroxide-containing sealers and AH26 in monkeys. Endod Dent Traumatol 5 (1989) 139-146
4. Tepel J., Darwisch M., and Hoppe W. Reaction of inflamed periapical tissue to intracanal medicament and root canal sealers. Endod Dent Traumatol 10 (1994) 233-238
5. Huang F.M., Chou M.Y., and Chang Y.C. Induction of cyclooxygenase-2 mRNA and protein expression by epoxy resin and zinc oxide-eugenol based root canal sealers in human osteoblastic cells. Biomaterials 24 (2003) 1869-1875
6. Huang F.M., and Chang Y.C. Prevention of the epoxy resin based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants. Biomaterials 26 (2005) 1847-1853
7. Huang F.M., Chou L.S.S., Chou M.Y., and Chang Y.C. Protective effect of NAC on formaldehyde-containing-ZOE-based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity in human osteoblastic cells. J Biomed Mater Res (Appl Biomater) 74B (2005) 768-773
8. Huang F.M., Tsai C.H., Yang S.F., and Chang Y.C. Induction of interleukin-6 and interleukin-8 gene expression by root canal sealers in human osteoblastic cells. J Endod 31 (2005) 679-683
9. Huang F.M., and Chang Y.C. Induction of heme oxygenase-1 expression by root canal sealers in human gingival fibroblasts is augmented by oxidative stress. J Biomed Mater Res (Appl Biomater) 80B (2007) 499-504
10. Huang F.M., Yang S.F., and Chang Y.C. Up-regulation of gelatinases and tissue type plasminogen activator by root canal sealers in human osteoblastic cells. J Endod 34 (2008) 291-294
11. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-9
12. Lacey D.L., Timms E., Tan H.L., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 (1998) 165-176
13. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 (1998) 3597-3602
14. Kong Y.Y., Feige U., Sarosi I., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 (1999) 304-309
15. Suda T., Takahashi N., Udagawa N., Jimi E., Gillespie M.T., and Martin T.J. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev 20 (1999) 345-357
16. Menezes R., Bramante C.M., da Silva K.B., et al. Receptor activator NFκB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. Oral Surg Oral Med Oral Pathol Oral Radiolol Endod 102 (2006) 404-409
17. Sabeti M., Simon J., Kermani V., Valles Y., and Rostein I. Detection of receptor activator of NF-κB ligand in apical periodontitis. J Endod 31 (2005) 17-18
18. Yang L.C., Huang F.M., Lin C.S., Liu C.M., Lai C.C., and Chang Y.C. Induction of interleukin-8 gene expression by black-pigmented Bacteroides in human pulp fibroblasts and osteoblasts. Int Endod J 36 (2003) 774-779
19. Chang Y.C., Tai K.W., Cheng M.H., Chou L.S.S., and Chou M.Y. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 27 (1998) 68-71
20. Chang Y.C., Huang F.M., Cheng M.H., Chou L.S.S., and Chou M.Y. In vitro evaluation of the cytotoxicity and genotoxicity of root canal medicines on human pulp fibroblasts. J Endod 24 (1998) 604-606
21. Skehan P. Assays of cell growth and cytotoxicity. In: Studizinski G.P. (Ed). Cell growth and apoptosis: a practical approach (1995), IRL Press, New York 176-178
22. Nelissen J.M.D.T., Torensma R., Pluyter M., et al. Molecular analysis of its hematopoiesis supporting osteoblastic cell line U2-OS. Exp Hematol 28 (2000) 422-432
23. Tai K.W., Huang F.M., and Chang Y.C. Cytotoxic evaluation of root canal filling materials on primary human oral fibroblast cultures and permanent hamster cell line. J Endod 27 (2001) 571-573
24. Tai K.W., Huang F.M., Huang M.S., and Chang Y.C. Assessment of genotoxicity of resin and zinc-oxide eugenol based root canal sealers employing in vitro mammalian test system. J Biomed Mater Res 59 (2002) 73-77
25. Huang F.M., Tai K.W., Chou M.Y., and Chang Y.C. Cytotoxicity of resin, zinc oxide eugenol, and calcium hydroxide based root canal sealers on human periodontal ligament cells and permanent V79 cells. Int Endod J 35 (2002) 153-158
26. Lindqvist L., and Otteskog O. Eugenol: liberation from dental materials and effect on human diploid fibroblast cells. Scand J Dent Res 89 (1981) 552-556
27. Ho Y.C., Huang F.M., and Chang Y.C. Mechanisms of cytotoxicity of eugenol in human osteoblastic cells in vitro. Int Endodont J 39 (2006) 389-393
28. Cohen B.I., Pagnillo M.K., Musikant B.L., and Dentsch A.S. Evaluation of the release of formaldehyde for three endodontic filling materials. Oral Health 88 (1998) 37-39
29. Leonardo M.R., de Silva L.A.B., Filho M.T., and de Silva R.S. Release of formaldehyde by 4 endodontic sealers. Oral Surg Oral Med Oral Pathol 88 (1999) 221-225
30. Ho Y.C., Huang F.M., and Chang Y.C. Cytotoxicity of formaldehyde on human osteoblastic cells is related to intracellular glutathione levels. J Biomed Mater Res (Appl Biomater) 83B (2007) 340-344
31. Boyle W.J., Smonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 (2003) 337-342
32. Mancini L., Paul-Clark M.J., Rosignoli G., et al. Calcitonin and prednisolone display antagonistic actions on bone and have synergistic effects in experimental arthritis. Am J Pathol 170 (2007) 1018-1027
33. Morgan K.T., Gross E.A., and Patterson D.L. Distribution, progression, and recovery of acute formaldehyde-induced inhibition of nasal mucociliary function in F-344 rats. Toxicol Appl Pharmacol 86 (1983) 161-176
34. Kozam G., and Mantell G.M. The effect of eugenol on oral mucous membranes. J Dent Res 57 (1978) 954-957
35. Lee Y.Y., Yang S.F., Ho W.H., Lee Y.H., and Hung S.L. Eugenol modulates cyclooxygenase-2 expression through the activation of nuclear factor kappa B in human osteoblasts. J Endod 33 (2007) 1172-1188
36. Kotake S., Sato K., Kim K.J., et al. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res 11 (1996) 88-95
37. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegrin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95 (1998) 3597-3602